Suppr超能文献

大麻素在大鼠中通过类CB1大麻素受体介导引起低血压和心动过缓。

Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

作者信息

Lake K D, Compton D R, Varga K, Martin B R, Kunos G

机构信息

Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613, USA.

出版信息

J Pharmacol Exp Ther. 1997 Jun;281(3):1030-7.

PMID:9190833
Abstract

Previous studies indicate that the CB1 cannabinoid receptor antagonist, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-met hyl-1H-pyrazole-3-carboxamide HCl (SR141716A), inhibits the anandamide- and delta9-tetrahydrocannabinol- (THC) induced hypotension and bradycardia in anesthetized rats with a potency similar to that observed for SR141716A antagonism of THC-induced neurobehavioral effects. To further test the role of CB1 receptors in the cardiovascular effects of cannabinoids, we examined two additional criteria for receptor-specific interactions: the rank order of potency of agonists and stereoselectivity. A series of cannabinoid analogs including the enantiomeric pair (-)-11-OH-delta9-THC dimethylheptyl (+)-11-OH-delta9-THC dimethylheptyl were evaluated for their effects on arterial blood pressure and heart rate in urethane anesthetized rats. Six analogs elicited pronounced and long lasting hypotension and bradycardia that were blocked by 3 mg/kg of SR141716A. The rank order of potency was (-)-11-OH-delta9-THC dimethylheptyl > or = (-)-3-[2-hydroxy-4-(1,1-dimethyl-heptyl)phenyl]-4-[3-hydroxy-propyl]c yclohexan-1-ol > (-)-3-[2-hydroxy-4-(1,1-dimethyl-heptyl)phenyl]-4-[3-hydroxy-propyl]c yclohexan-1-ol > THC > anandamide > or = (-)-3-[2-hydroxy-4-(1,1-dimethyl-heptyl)phenyl]-4-[3-hydroxy-propyl]c yclohexan-1-ol, which correlated well with CB1 receptor affinity or analgesic potency (r = 0.96-0.99). There was no hypotension or bradycardia after palmitoylethanolamine or (+)-11-OH-delta9-THC dimethylheptyl. An initial pressor response was also observed with THC and anandamide, which was not antagonized by SR141716A. We conclude that the similar rank orders of potency, stereoselectivity and sensitivity to blockade by SR141716A indicate the involvement of CB1-like receptors in the hypotensive and bradycardic actions of cannabinoids, whereas the mechanism of the pressor effect of THC and anandamide remains unclear.

摘要

先前的研究表明,CB1大麻素受体拮抗剂N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺盐酸盐(SR141716A),在麻醉大鼠中抑制花生四烯酸乙醇胺和δ9-四氢大麻酚(THC)诱导的低血压和心动过缓,其效力与SR141716A拮抗THC诱导的神经行为效应时所观察到的效力相似。为了进一步测试CB1受体在大麻素心血管效应中的作用,我们研究了受体特异性相互作用的另外两个标准:激动剂效力的排序和立体选择性。评估了一系列大麻素类似物,包括对映体对(-)-11-OH-δ9-THC二甲基庚基(+)-11-OH-δ9-THC二甲基庚基对氨基甲酸乙酯麻醉大鼠动脉血压和心率的影响。六种类似物引起明显且持久的低血压和心动过缓,3mg/kg的SR141716A可阻断这些作用。效力排序为(-)-11-OH-δ9-THC二甲基庚基≥(-)-3-[2-羟基-4-(1,1-二甲基庚基)phenyl]-4-[3-羟基丙基]环己醇>(-)-3-[2-羟基-4-(1,1-二甲基庚基)phenyl]-4-[3-羟基丙基]环己醇>THC>花生四烯酸乙醇胺≥(-)-3-[2-羟基-4-(1,1-二甲基庚基)phenyl]-4-[3-羟基丙基]环己醇,这与CB1受体亲和力或镇痛效力密切相关(r = 0.96 - 0.99)。棕榈酰乙醇胺或(+)-11-OH-δ9-THC二甲基庚基给药后未出现低血压或心动过缓。THC和花生四烯酸乙醇胺给药后还观察到初始升压反应,该反应未被SR141716A拮抗。我们得出结论,效力、立体选择性以及对SR141716A阻断的敏感性的相似排序表明,类CB1受体参与了大麻素的降压和减慢心率作用,而THC和花生四烯酸乙醇胺升压效应的机制仍不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验